Senate panel: Dementia a $20 trillion threat

Senate panel: Dementia a $20 trillion threat.

The United States has to continue to make funding scientific research on Alzheimer’s disease and other causes of dementia a top priority, according to the members of the Senate Special Committee on Aging.

The fiscal climate may be challenging, but the Alzheimer’s Association is estimating that, unless the country finds some way to prevent Alzheimer’s disease (AD), cure it or substantially improve treatments for disease, the condition will cost the United States alone about $20 trillion over the next 40 years, the committee has concluded in a report in which it looks at how other countries are handling dementia.